Welcome to LookChem.com Sign In|Join Free

CAS

  • or

28128-41-8

Post Buying Request

28128-41-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

28128-41-8 Usage

Description

8-Aminoguanine, also known as 8-aminopurine, is an organic compound with the chemical formula C5H5N5. It is a purine derivative and is structurally similar to guanine, a nucleobase found in DNA and RNA. 8-Aminoguanine is a solid substance and is known for its unique chemical properties that make it useful in various applications.

Uses

Used in Pharmaceutical Industry:
8-Aminoguanine is used as a therapeutic agent for its ability to accelerate DNA tetramolecular G-quadruplex formation. This property makes it a promising candidate in the development of new drugs targeting specific genetic disorders and diseases related to DNA structure and function.
Used in Research and Development:
In the field of molecular biology and genetics, 8-Aminoguanine is used as a research tool to study the structure and function of DNA and RNA. Its ability to interact with nucleic acids and influence their properties makes it a valuable compound for understanding the molecular mechanisms underlying various biological processes.
Used in Chemical Synthesis:
8-Aminoguanine is also used as a starting material or intermediate in the synthesis of other purine-based compounds, which have potential applications in the pharmaceutical, agrochemical, and materials science industries.

Check Digit Verification of cas no

The CAS Registry Mumber 28128-41-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,8,1,2 and 8 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 28128-41:
(7*2)+(6*8)+(5*1)+(4*2)+(3*8)+(2*4)+(1*1)=108
108 % 10 = 8
So 28128-41-8 is a valid CAS Registry Number.
InChI:InChI=1/C5H6N6O/c6-4-8-1-2(9-4)10-5(7)11-3(1)12/h1H,(H5,6,7,8,9,10,11,12)

28128-41-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,8-diamino-3,7-dihydropurin-6-one

1.2 Other means of identification

Product number -
Other names 2,8-diamino-1,9-dihydro-6h-purin-6-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:28128-41-8 SDS

28128-41-8Synthetic route

8-<(4-bromophenyl)azo>guanine
79953-02-9

8-<(4-bromophenyl)azo>guanine

8-aminoguanine
28128-41-8

8-aminoguanine

Conditions
ConditionsYield
With sodium dithionite In sodium hydroxide at 90℃; for 48h; pH 9;60%
8-nitroguanine
168701-80-2

8-nitroguanine

8-aminoguanine
28128-41-8

8-aminoguanine

Conditions
ConditionsYield
With sodium disulfite In water at 20℃; for 0.166667h;
With sodium dithionite Product distribution;
2-amino-1,9-dihydro-6H-purin-6-one
73-40-5

2-amino-1,9-dihydro-6H-purin-6-one

8-aminoguanine
28128-41-8

8-aminoguanine

Conditions
ConditionsYield
Stage #1: 2-amino-1,9-dihydro-6H-purin-6-one With 4-chlorophenyldiazonium salt
Stage #2: With sodium hydrogensulfite
Multi-step reaction with 2 steps
1: peroxynitrite / aq. phosphate buffer / 0.08 h / 20 °C / pH 7
2: sodium dithionite
View Scheme
Multi-step reaction with 2 steps
1: aq. HCl; ammonium formate; peroxonitrite / 0.03 h / 20 °C / pH 6.8 - 7.0
2: sodium hydrosulfite / H2O / 0.17 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: 75 percent / aq. NaOH / 0.25 h / 0 °C / pH 10-11
2: 60 percent / sodium dithionite / aq. NaOH / 48 h / 90 °C / pH 9
View Scheme
8-aminoguanosine
3868-32-4

8-aminoguanosine

8-aminoguanine
28128-41-8

8-aminoguanine

Conditions
ConditionsYield
With hydrogenchloride In water at 70℃; for 1h;
8-aminoguanine
28128-41-8

8-aminoguanine

2,8-diamino-6-chloropurine

2,8-diamino-6-chloropurine

Conditions
ConditionsYield
With N,N-dimethyl-aniline; trichlorophosphate for 0.5h; Heating;63%
8-aminoguanine
28128-41-8

8-aminoguanine

2'-Deoxycytidine
951-77-9

2'-Deoxycytidine

8-amino-2'-deoxyguanosine
13389-04-3

8-amino-2'-deoxyguanosine

Conditions
ConditionsYield
With trans-N-deoxyribosylase from Lactobacillus helveticus In water at 37℃; for 15h; Product distribution; trans-deoxyribosylation; Enzymatic reaction; product analyzed by HPLC;58 % Chromat.
8-aminoguanine
28128-41-8

8-aminoguanine

N,N-dimethylformamide dineopentyl acetal
4909-78-8

N,N-dimethylformamide dineopentyl acetal

8-amino-2,8-bis(N-dimethylaminomethylene)guanine

8-amino-2,8-bis(N-dimethylaminomethylene)guanine

Conditions
ConditionsYield
In N,N-dimethyl-formamide
8-aminoguanine
28128-41-8

8-aminoguanine

[2-(2,8-diamino-6-oxo-1,6-dihydro-purin-9-yl)-ethoxymethyl]-phosphonic acid diisopropyl ester

[2-(2,8-diamino-6-oxo-1,6-dihydro-purin-9-yl)-ethoxymethyl]-phosphonic acid diisopropyl ester

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: dimethylformamide
2: NaH / dimethylformamide
3: Me3SiBr / acetonitrile
View Scheme
8-aminoguanine
28128-41-8

8-aminoguanine

[2-(2,8-diamino-6-oxo-1,6-dihydro-purin-7-yl)-ethoxymethyl]-phosphonic acid diisopropyl ester

[2-(2,8-diamino-6-oxo-1,6-dihydro-purin-7-yl)-ethoxymethyl]-phosphonic acid diisopropyl ester

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: dimethylformamide
2: NaH / dimethylformamide
3: Me3SiBr / acetonitrile
View Scheme
8-aminoguanine
28128-41-8

8-aminoguanine

{2-[2,8-bis-(dimethylamino-methyleneamino)-6-oxo-1,6-dihydro-purin-9-yl]-ethoxymethyl}-phosphonic acid diisopropyl ester

{2-[2,8-bis-(dimethylamino-methyleneamino)-6-oxo-1,6-dihydro-purin-9-yl]-ethoxymethyl}-phosphonic acid diisopropyl ester

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: dimethylformamide
2: NaH / dimethylformamide
View Scheme
8-aminoguanine
28128-41-8

8-aminoguanine

{2-[2,8-bis-(dimethylamino-methyleneamino)-6-oxo-1,6-dihydro-purin-7-yl]-ethoxymethyl}-phosphonic acid diisopropyl ester

{2-[2,8-bis-(dimethylamino-methyleneamino)-6-oxo-1,6-dihydro-purin-7-yl]-ethoxymethyl}-phosphonic acid diisopropyl ester

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: dimethylformamide
2: NaH / dimethylformamide
View Scheme
8-aminoguanine
28128-41-8

8-aminoguanine

2,8-Diamino-9-((S)-2-hydroxy-3-trityloxy-propyl)-1,9-dihydro-purin-6-one

2,8-Diamino-9-((S)-2-hydroxy-3-trityloxy-propyl)-1,9-dihydro-purin-6-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: dimethylformamide
2: Cs2CO3 / dimethylformamide
3: Me3SiBr / acetonitrile
View Scheme
8-aminoguanine
28128-41-8

8-aminoguanine

2,8-Diamino-7-((S)-2-hydroxy-3-trityloxy-propyl)-1,7-dihydro-purin-6-one

2,8-Diamino-7-((S)-2-hydroxy-3-trityloxy-propyl)-1,7-dihydro-purin-6-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: dimethylformamide
2: Cs2CO3 / dimethylformamide
3: Me3SiBr / acetonitrile
View Scheme
8-aminoguanine
28128-41-8

8-aminoguanine

N'-[8-(dimethylamino-methyleneamino)-9-(2-hydroxy-3-trityloxy-propyl)-6-oxo-6,9-dihydro-1H-purin-2-yl]-N,N-dimethyl-formamidine

N'-[8-(dimethylamino-methyleneamino)-9-(2-hydroxy-3-trityloxy-propyl)-6-oxo-6,9-dihydro-1H-purin-2-yl]-N,N-dimethyl-formamidine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: dimethylformamide
2: Cs2CO3 / dimethylformamide
View Scheme
8-aminoguanine
28128-41-8

8-aminoguanine

N'-[8-(dimethylamino-methyleneamino)-7-(2-hydroxy-3-trityloxy-propyl)-6-oxo-6,7-dihydro-1H-purin-2-yl]-N,N-dimethyl-formamidine

N'-[8-(dimethylamino-methyleneamino)-7-(2-hydroxy-3-trityloxy-propyl)-6-oxo-6,7-dihydro-1H-purin-2-yl]-N,N-dimethyl-formamidine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: dimethylformamide
2: Cs2CO3 / dimethylformamide
View Scheme
8-aminoguanine
28128-41-8

8-aminoguanine

(2-{2,8-diamino-1-[2-(diisopropoxy-phosphorylmethoxy)-ethyl]-6-oxo-1,6-dihydro-purin-7-yl}-ethoxymethyl)-phosphonic acid diisopropyl ester

(2-{2,8-diamino-1-[2-(diisopropoxy-phosphorylmethoxy)-ethyl]-6-oxo-1,6-dihydro-purin-7-yl}-ethoxymethyl)-phosphonic acid diisopropyl ester

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: dimethylformamide
2: NaH / dimethylformamide
3: Me3SiBr / acetonitrile
View Scheme
8-aminoguanine
28128-41-8

8-aminoguanine

{2-[1-[2-(diisopropoxy-phosphorylmethoxy)-ethyl]-2,8-bis-(dimethylamino-methyleneamino)-6-oxo-1,6-dihydro-purin-7-yl]-ethoxymethyl}-phosphonic acid diisopropyl ester

{2-[1-[2-(diisopropoxy-phosphorylmethoxy)-ethyl]-2,8-bis-(dimethylamino-methyleneamino)-6-oxo-1,6-dihydro-purin-7-yl]-ethoxymethyl}-phosphonic acid diisopropyl ester

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: dimethylformamide
2: NaH / dimethylformamide
View Scheme
8-aminoguanine
28128-41-8

8-aminoguanine

2,8-Diamino-1,7-bis-((S)-2-hydroxy-3-trityloxy-propyl)-1,7-dihydro-purin-6-one

2,8-Diamino-1,7-bis-((S)-2-hydroxy-3-trityloxy-propyl)-1,7-dihydro-purin-6-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: dimethylformamide
2: Cs2CO3 / dimethylformamide
3: Me3SiBr / acetonitrile
View Scheme
8-aminoguanine
28128-41-8

8-aminoguanine

N'-[8-(dimethylamino-methyleneamino)-1,7-bis-(2-hydroxy-3-trityloxy-propyl)-6-oxo-6,7-dihydro-1H-purin-2-yl]-N,N-dimethyl-formamidine

N'-[8-(dimethylamino-methyleneamino)-1,7-bis-(2-hydroxy-3-trityloxy-propyl)-6-oxo-6,7-dihydro-1H-purin-2-yl]-N,N-dimethyl-formamidine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: dimethylformamide
2: Cs2CO3 / dimethylformamide
View Scheme
8-aminoguanine
28128-41-8

8-aminoguanine

8-amino-O6-benzylguanine

8-amino-O6-benzylguanine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 63 percent / POCl3, N,N-dimethylaniline / 0.5 h / Heating
2: 21 percent / Na / 5 h / 130 °C
View Scheme

28128-41-8Downstream Products

28128-41-8Relevant articles and documents

HETEROCYCLIC GTP CYCLOHYDROLASE 1 INHIBITORS FOR THE TREATMENT OF PAIN

-

Page/Page column 85, (2011/04/19)

The present invention relates to the field of small molecule heterocyclic inhibitors of GTP cyclohydrolase (GCH-I), or a tautomer, prodrug, or pharmaceutically acceptable salt thereof. The invention also features pharmaceutical compositions of the compounds and the medical use of these compounds for the treatment or prevention of pain (e.g., inflammatory pain, nociceptive pain, functional pain, or neuropathic pain).

Analysis of peroxynitrite reactions with guanine, xanthine, and adenine nucleosides by high-pressure liquid chromatography with electrochemical detection: C8-nitration and -oxidation

Sodum, Rama S.,Fiala, Emerich S.

, p. 438 - 450 (2007/10/03)

Peroxynitrite, the reaction product of nitric oxide and superoxide anion, and a powerful oxidant, was found to nitrate as well as oxidize adenine, guanine, and xanthine nucleosides. A highly sensitive reverse-phase HPLC method with a dual-mode electrochemical detector, which reduces the nitro product at the first electrode and detects the reduced product by oxidation at the second electrode, was applied to detect femtomole levels of 8-nitroguanine and 8-nitroxanthine. This method was used to separate and identify the products of nitration and oxidation from the reactions of nucleosides with peroxynitrite. Peroxynitrite nitrates deoxyguanosine at neutral pH to give the very unstable 8-nitrodeoxyguanosine, in addition to 8-nitroguanine. 8-Nitrodeoxyguanosine, with a half-life of ~10 min at room temperature and ≤3 min at 37 °C, hydrolyzes at pH 7 to 8-nitroguanine. A decrease in the reaction pH resulted in a decrease in the level of C8-nitration. Peroxynitrite also oxidizes deoxyguanosine in a pH-dependent manner, to give 8-oxodeoxyguanosine with a maximum yield (0.5-0.7%) at pH 5. Guanosine and xanthosine exhibit reactivity similar to that of deoxyguanosine toward peroxynitrite at neutral pH, producing only the corresponding 8-nitronucleosides as well as 8-nitroguanine and 8-nitroxanthine, respectively. 8-Nitroguanosine at pH 7, with a half-life of several weeks at 5 °C and 5 h at 37 °C, was much more stable than 8-nitrodeoxyguanosine. C8-nitration was confirmed by dithionite reduction to the corresponding amino nucleosides, which cochromatographed with synthesized 8-amino nucleoside standards. In contrast to guanine nucleosides, adenine nucleosides undergo peroxynitrite-mediated C8 oxidation even at neutral pH to give the corresponding 8-oxoadenine nucleosides in ~0.3% yield. Adenine nitration, though minor compared to C8-oxidation, appears to occur at both C2 and C8 positions of the adenine ring. Lowering the reaction pH from 7 to 5 results in 2.4- and 2.2-fold increases in the yields of 8-oxo-dA and 8-oxo-Ado, respectively, but the level of nitration is not altered.

Formation and reactions of N7-aminoguanosine and derivatives

Guengerich, F. Peter,Mundkowski, Ralf G.,Voehler, Markus,Kadlubar, Fred F.

, p. 906 - 916 (2007/10/03)

Arylamines are mutagens and carcinogens and are thought to initiate tumors by forming adducts with DNA. The major adducts are C8-guanyl, and we have previously suggested a role for guanyl-N7 intermediates in the formation process. N7-Aminoguanosine (Guo) was synthesized and characterized, with the position of the NH2 at N7 established by two- dimensional rotating frame Overhauser enhancement NMR spectroscopy. In DMF, N7-NH2Guo formed C8-NH2Guo and the cyclic product C8:5'-O-cycloGuo. In aqueous media, these products were formed along with 8-oxo-7,8-dihydroGuo, N7-NH2guanine, and a product characterized as a purine 8,9-ring-opened derivative (N-aminoformamidopyrimidine). The rate of aqueous decomposition of N7-NH2Guo increased with pH, with a t( 1/2 ) of 10 h at pH 7 and a t( 1/2 ) of 2 h at pH 9. The rate of migration of NH2 from N7 to C8 is fast enough to explain the formation of C8-NH2Guo from the reaction of 2,4- dinitrophenoxyamine with Guo but not the formation of C8-(arylamino)Guo in the reaction of Guo with aryl hydroxylamine esters; however, the fluorenyl moiety may facilitate the proposed rearrangement by stabilizing an incipient negative charge in the transfer. In the reaction of Guo with N-hydroxy-2- aminofluorene and acetylsalicylic acid, a peak with the mass spectrum expected for N7-(2-aminofluorenyl)Guo was detected early in the reaction and was distinguished from C8-(2-aminofluorenyl)Guo. NMR experiments with [8- 13C]Guo also provided some additional support for transient formation of N7-(2-aminofluorenyl)Guo. We conclude that a guanyl-N7 intermediate is reasonable in the reaction of activated arylamines with nucleic acids, although an exact rate of transfer of an N7-arylamine group to the C8 position has not yet been quantified. The results provide an explanation for the numerous products associated with modification of DNA by activated arylamines. However, the contribution of 'direct' reaction at the guanine C8 atom cannot be excluded.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 28128-41-8